Jefferies Assumes Cara Therapeutics (CARA) at Buy

May 30, 2023 3:01 AM EDT Send to a Friend
Jefferies analyst Dennis Ding assumes coverage on Cara Therapeutics (NASDAQ: CARA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login